← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Neurodex Inc
Arlington, MA
$5,808,333
Total funding
4
Grants
Funding over time
peak $3.1M · FY2019–25$5M$3.8M$2.5M$1.3M$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,279,305 · 3
DOD$529,028 · 1
By mechanism
R44$5,067,005 · 2
—$529,028 · 1
R43$212,300 · 1
Investigators at Neurodex Inc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Blood-based Biomarker for Characterizing Progression and Therapeutic Response in Amyotrophic Lateral Sclerosis$2,147,016
R44 · FY2024 · NS
Development of a Blood-based Test for Identifying Synucleinopathy in Patients with Dementia$1,009,625
R44 · FY2023 · NS
Development of a Blood-based Test for Identifying Synucleinopathy in Patients with Dementia$942,163
R44 · FY2024 · NS
TDP43 IN CIRCULATING NEURON DERIVED EXTRACELLULAR VESICLES AS PROGNOSTIC AND DIAGNOSTIC ALS BIOMARKER$529,028
· FY2025 · Defense Health Agency
Development of a Blood-based Test for Identifying Synucleinopathy in Patients with Dementia$518,202
R44 · FY2025 · NS
Development of a Blood-based Test for Identifying Synucleinopathy in Patients with Dementia$449,999
R44 · FY2022 · NS
Presymptomatic Diagnostic Tools for Alzheimers Disease by Blood Neuron Derived Exosome Analysis$212,300
R43 · FY2019 · AG